Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Chemical Chaperones for the Prevention of Antipsychotic-Induced Impairments in Glucose Metabolism

FY 2023-24

Summary
Antipsychotics are a class of medications used to treat schizophrenia, a severe mental illness that affects approximately 1% of the Canadian population. Although these medications can be very effective, they also have many significant side effects, including an increased risk of developing type 2 diabetes. The mechanism for this increased risk is not fully understood; however, it was recently discovered that these medications cause stress on brain cells in regions important for maintaining nutrient balance, including sugars. When under stress, these cells are unable to function properly, which suppresses the body's ability to regulate nutrients; this may contribute to persistently high blood sugar levels. These brain cells have many processes to relieve stress on their own, including a class of molecules called chemical chaperones. These chaperones are responsible for ensuring that all cellular components are assembled and functioning properly. Therefore, the current project aims to release the brain cells of stress by administering chemical chaperones, in a rat model of short-term antipsychotic use. In this model, the rodent’s metabolism will be manipulated to rule out the effects of other organs, including the pancreas and liver, while focusing on the brain. It is expected that the administered chemical chaperones will relieve brain cell stress, subsequently returning blood sugar levels to normal. This study is crucial to the field of psychiatry as it can help uncover a mechanism for the increased risk of diabetes in individuals taking antipsychotics. Following the successful completion of this project, a similar clinical trial will be done to ensure that it is both safe and effective for widespread use.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
506096
Name
Humber Bailey
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Chemical Chaperones for the Prevention of Antipsychotic-Induced Impairments in Glucose Metabolism
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antipsychotics; Diabetes; Endoplasmic Reticulum Stress; Glucose; Insulin; Metabolic Dysfunction; Schizophrenia
Abstract
Antipsychotics are a class of medications used to treat schizophrenia, a severe mental illness that affects approximately 1% of the Canadian population. Although these medications can be very effective, they also have many significant side effects, including an increased risk of developing type 2 diabetes. The mechanism for this increased risk is not fully understood; however, it was recently discovered that these medications cause stress on brain cells in regions important for maintaining nutrient balance, including sugars. When under stress, these cells are unable to function properly, which suppresses the body's ability to regulate nutrients; this may contribute to persistently high blood sugar levels. These brain cells have many processes to relieve stress on their own, including a class of molecules called chemical chaperones. These chaperones are responsible for ensuring that all cellular components are assembled and functioning properly. Therefore, the current project aims to release the brain cells of stress by administering chemical chaperones, in a rat model of short-term antipsychotic use. In this model, the rodent’s metabolism will be manipulated to rule out the effects of other organs, including the pancreas and liver, while focusing on the brain. It is expected that the administered chemical chaperones will relieve brain cell stress, subsequently returning blood sugar levels to normal. This study is crucial to the field of psychiatry as it can help uncover a mechanism for the increased risk of diabetes in individuals taking antipsychotics. Following the successful completion of this project, a similar clinical trial will be done to ensure that it is both safe and effective for widespread use.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Humber, Bailey
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~